Read the latest from the Driehaus Life Sciences Team for their thoughts on COVID19, the market reaction and how they are approaching investing in life sciences companies in this market.
We are living in unprecedented times. The Covid-19 pandemic has caused global devastation on a scale that was unfathomable just a couple months ago. Faced with extreme fear and uncertainty, global financial markets responded with frenzied selling across all asset classes. This period – which on many metrics surpasses the Great Financial Crisis in terms of uncertainty and financial stress – has led to a swift and significant repricing of every pocket of the financial markets.
Featured Commentary
COVID19: Thoughts from the Driehaus Life Sciences Team
By US Growth Equities
Read the latest from the Driehaus Life Sciences Team for their thoughts on COVID19, the market reaction and how they are approaching investing in life sciences companies in this market.
Driehaus Event Driven March 2020 Commentary and Attribution
By Alternative Investments
We are living in unprecedented times. The Covid-19 pandemic has caused global devastation on a scale that was unfathomable just a couple months ago. Faced with extreme fear and uncertainty, global financial markets responded with frenzied selling across all asset classes. This period – which on many metrics surpasses the Great Financial Crisis in terms of uncertainty and financial stress – has led to a swift and significant repricing of every pocket of the financial markets.